Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
D004273:DNA, Neoplasm / Q000378:metabolism; D003630:Daunorubicin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans
D004273:DNA, Neoplasm; D004317:Doxorubicin; D003630:Daunorubicin